Introduction
Myasthenia gravis (MG)' is an autoimmune disorder that affects neuromuscular junctions (1) . The clinical symptoms of myasthenia gravis include muscle weakness after repeated exercise, diurnal fluctuation of the symptoms, frequent concurrence and family history of other immunological disorders such as asthma, thyroiditis, and atopic dermatitis. Muscle weakness is markedly improved by the Tensilon test. Laboratory examinations generally reveal frequent occurrence of thymus enlargement or thymoma, presence of antiacetylcholine receptor antibodies, and waning phenomenon on electromyographic examination (1) .
One of the important features in this disorder is its strong association with the HLA antigens (2) (3) (4) . In Caucasians, a number of studies showed firm association between this disorder and HLA-A1, B8, and DR3 (3) (4) (5) . In Orientals, however, the association has been ambiguous. The 8th International Histocompatibility Workshop (6) , for example, failed to find any significant association between the disorder and HLA in Orientals.
To date, most of the studies on HLA in Oriental MG have been limited to the patients who developed the disorder in the adulthood (7, 8) . However, in Japanese the large number of the patients develop the disorder before 3 yr ofage (9, 10) . The age at onset of MG in Japanese shows a bimodal distribution: the first and highest peak is before the age of 3 yr and the second and lower peak in the third decade (9, 10) . This is in contrast to Caucasian MG, in which the distribution generally shows a single adulthood peak (1) : in the third decade for females and in the fifth or sixth decades for males. In this study, we investigated the HLA antigens in a total of 104 Japanese MG patients that developed the disorder at various ages, from 1 mo to 67 yr. We also analyzed HLA haplotypes in 41 families.
Methods
Patients. Patients were 104 randomly selected Japanese (24 males and 80 females) outpatients at Segawa Neurological Clinic for Children (Chiyoda-ku, Tokyo) and the Department of Neurology at the Juntendo University (Bunkyo-ku, Tokyo) ( Table I ). The diagnosis was made clinically before HLA typing. All the patients met the standard diagnostic criteria for MG that were reevaluated by the Japanese Committee on Neuroimmunological Disorders (11) . All of them showed muscle weakness after repeated exercise, diurnal fluctuation of the symptoms, and marked effectiveness of the Tensilon test. The clinical details and diagnosis of the patients who developed the disorder in the childhood were described elsewhere (12) (13) (14) . All the patients reported in the previous studies were included (12) (13) (14) (15) (16) . Patients with neonatal and congenital MG or those having thymoma were excluded from the present study. The patients were arbitrarily classified into four subgroups according to the age at onset (13, 14) : subgroup I includes 43 patients that developed the disorder before the age of 3 yr, subgroup II includes 20 patients that developed MG between 3 and 5 yr of age; subgroup III includes 18 patients between 6 and 14; and subgroup IV includes 23 patients after 15 yr of age (Table I) . Controls were 220 apparently healthy randomly selected Japanese.
Family study. A total of 41 families were selected and each family member was examined to deduce the HLA haplotypes. Four families were intentionally included since two of the families had monozygotic twins, one had dizygotic twins, and the other had two children with MG; however, all the other families were selected at random. Among the 41 families, 21 of the probands (families 1-21) belonged to the subgroup I, 10 (families [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] to the subgroup II, and 10 (families [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] to the subgroup III. In this study, no family with a proband in subgroup IV was included. The haplotype and segregation data of the control Japanese families were obtained from the 8th Japan HLA workshop data (17) . I  0-2  10  33  43  II  3-5  6  14  20  III  6-14  5  13  18  IV  15-3  20  23   Total  24  80  104 * Subgroups were according to Segawa ( 13) and Segawa et al. ( 14) .
HLA typing. Serological HLA typing was performed by the modified two-stage complement-dependent microcytotoxicity method as described previously (18) . The typing sera were obtained at Blood Transfusion Service, Tokyo University Hospital, or through serum exchange. The typing sera distributed at the 9th and 10th International Histocompatibility Workshop were also used to determine HLA antigens. At least three sera were used to type a single HLA specificity. Complement allotypes were typed according to the method ofSim and Cross ( 19) and to the method of Alper and others (20) .
Statistical analysis. For comparing HLA antigen frequencies between the patients and healthy subjects, P values were obtained by the chi square or the Fisher exact test. Corrected P values (Pc) were calculated as Pc = I -(I -P)", where n stands for the number of the antigens examined or the number of detected polymorphic restriction fragments. Relative risks were calculated by the method ofWoolf (21) . To analyze synergistic interaction statistically, the S values were calculated according to the method of Rothman (22) .
Two different kinds ofgenetic models were examined to see ifthey could explain the observed HLA phenotype frequencies. The first model assumes a single disease-predisposing gene that is in linkage disequilibrium with only one HLA antigen such as DR9. The second model assumes a single disease gene that is in linkage disequilibrium with two HLA antigens such as DR9 and DRw13. Both dominant and recessive modes of inheritance were evaluated for each model. For the first model, expected genotype frequencies under the dominant inheritance were calculated by the moment method as described by Thomson (23) and those under the recessive inheritance were calculated by the counting method of maximum likelihood as described previously ( 18) . For the second model, the expected frequencies were computed according to the maximum likelihood method (23) . Attributable risks were calculated according to Thomson (24) .
Southern analysis. Among the HLA-typed patients in the subgroup I (age at onset < 3 yr), patients were further studied for the DQA, DQB, and DPB restriction fragment length polymorphisms (RFLP). One DQw3-negative patient was intentionally selected, while the other DQw3-positive patients were randomly selected from the remaining patients. Southern analysis was performed as described previously (25) . Briefly, genomic DNA was isolated from the peripheral blood leukocytes (23 Table II shows the HLA antigen frequencies in Japanese patients with myasthenia gravis subclassified according to the age at onset. As for class I antigens, only the frequencies of Aw33 and B44 were increased significantly in the subgroup I as compared with the healthy control. No patients had B8, which is associated with MG in caucasians (2-5).
As for class II antigens, the frequencies ofDR9 and DRw13 were both increased significantly in the subgroup I as compared with the control. The relative risks for DR9 and DRw13 in subgroup I were 16.4 and 7.1, respectively. Fig. I plots the DR antigen frequencies in each case and surrounding 12 cases combined against the age of onset of the case. These frequencies decreased rapidly until 10 yr ofage and reached the almost constant level, although the DR9 frequency displayed a small increase in the third decade ( Fig. 1) .
The DRw13 frequency was slightly higher in males (8 in 10, 80%) than in females (17 in 33, 52%) in subgroup I, but this difference was not statistically significant. No antigens showed significant difference between sexes in each subgroup.
The HLA-DR antigen frequencies in subgroup I were significantly different from those in all the other subgroups combined (X2d.1=4 = 24.7, P < 0.0001).
As for the DQ antigens, all but one patient in the subgroups I through III were DQw3 positive (relative risk of 28.0 in subgroup I). The DQw3 frequency remained almost 100% before 15 yr ofage at onset; after 15 yr, it declined (Fig. 2) . The DQwl frequency showed a bimodal distribution: the first peak before the age of 5, and the second peak in the third decade. The Table I .
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Age at onset (in years) DQw4 and DQw7 showed patterns complimentary to that of DQwl, with a peak of -10 yr of age. No patients had DR3 or DQw2, which are frequently found in caucasian patients with MG. Genotype frequencies. In the subgroup I, the number of DR9/DRw 13 heterozygotes was increased significantly as compared with that in controls (x2 = 88.7, P < 10-20) (Table  III) . The relative risk to develop MG was 37.4 for the DR9/ DRwl 3 heterozygotes. Although there was one DR9 homozygote in the subgroup I, there was no DRw1 3 homozygote in all the patient groups. The relative risks for DR9/DRwl3 were not as high in other subgroups as in subgroup I. The DQwl/ DQw3 heterozygotes were also significantly increased in the subgroup I (Table III) .
Synergistic interaction. The S value for DR9 and DRw1 3 computed by the method of Rothman (22) was 8.63 in subgroup I. This indicates that the observed risk for the DR9/ DRwl 3 subjects to develop MG was 8.63 times higher than the expected value under the assumption that DR9 and DRw1 3 has no synergistic interaction (P < 0.0001). However, in subgroups II, III, and IV, no statistically significant synergistic interaction was observed.
Single disease allele model. To investigate the underlying genetics in early childhood-onset MG, two sets of genetic 1 and 36 (P < 0.05 for the dominant and P < 10-6 for the recessive models). Similarly, single disease allele models in linkage with only DRw13 failed to explain the DRw13 genotype frequencies (P < 0.05 for the dominant and P < 0.001 for the recessive models).
Another model is the one that assumes a single diseasepredisposing allele that is in linkage disequilibrium with both DR9 and DRw1 3. Table IV shows the expected DR9 and DRw13 genotype frequencies calculated under strict dominant and recessive models of the disease allele. Both models were rejected (the recessive model at P < 0.02, the dominant model at P < 0.003.) Similar analysis also rejected a single disease allele model in linkage disequilibrium with both DQwl and DQw3 (Table IV) Thomson (23) . The kI and k2 values represent the proportions of the DR9 and DRw 13 (or DQw1 and DQw3) haplotypes in the disease susceptibility haplotypes. To calculate chi square values, categories with small number were added to make each category bigger than 5. The patients analyzed here were the probands of subgroup I. The control DR9 and DRw1 3 allele frequencies were calculated from the controls here.
MG before 15 yr of age (Fig. 3) . In the families with two monozygotic twins (families 11 and 22) and one dizygotic twin (family 6), only one ofeach twin developed MG. In the family with two affected children (family 7), all the HLA haplotypes were different between the children.
In these 41 families, 31 probands had a DR9 haplotype (Table V) . Among these DR9 haplotypes, the most frequent haplotype was Bw6 1-DR9, which is also the most frequent haplotype in the normal Japanese population. The second most frequent haplotype in the patients was Cwl l-Bw46-DR9. The complotype BFS-C4A4-C4B2 was linked with this haplotype in all of the cases. This haplotype is quite rare in control Japanese (17) . This complotype was the same as that found in the Chinese Cwl l-Bw46-DR9 haplotype. HLA-DQ and DPB RFLP. A RFLP analysis using the DQB probe showed an increased frequency of the Eco RI 20-kb fragment (P < 0.00001) and a 100% presence ofthe Taq I 1.9-kb fragment (P < 0.003) (including one DQw3 negative case) (Table VI) . Representative blots are shown in Fig. 4 . The DQA1 RFLP also revealed complete presence of the Taq I 5.4-kb fragment (P < 0.03). As for the DQA2 and DPB RFLP, none of the polymorphic fragments showed significant deviation. We studied all the possible combination of the DQA, DQB genes and DR specificities in the 23 patients that were examined for both DQA and DQB polymorphisms (Table VII) 
Discussion
This is the first study that demonstrates strong association between the HLA antigens and MG in Japanese. This is also the first study that analyzed extensively the HLA antigens in Japanese children with MG.
The HLA specificities that showed strong association were DR9, DRw13, DQwl, DQw3, and related DQA1 and DQB1 gene restriction fragments. The increase of Aw33 and B44 would be secondary to the DRw13 increase, since Aw33 and B44 have a strong linkage disequilibrium with DRw13 in Japanese (17) . No patients had DR3 or DQw2. Since DR3 and DQw2 are associated with Caucasian MG (2-5), our results demonstrated that Japanese MG differs from Caucasian MG in the immunogenetic respect.
The strength of association was dependent on the age of onset. The association was strongest before 3 yr of age, then it decreased with the age of onset. Pirskanen et al. (4) and Fritze et al. (2) showed the HLA-B8 and MG association was stronger in Caucasian patients with age at onset earlier than 35 yr and 40 yr, respectively. Yoshida et al. (7) showed B12 was more frequently found in Japanese patients that developed MG earlier than 30 yr. However, none of these previous studies included cases with age at onset as early as ours.
The difference in the HLA frequencies in the age at onset is striking. To date, only few diseases have been known to show such great difference. One of the disorders is diabetes mellitus. In diabetes mellitus, there is a clear HLA association in the childhood-onset type, while no strong association in the adultonset type (5) . This phenomenon is explained by the fact that although both diseases share similar clinical symptoms the underlying pathophysiologies are different. The other one is rheumatoid arthritis. Rheumatoid arthritis is associated with DR4 in the adult type and with B27 and DR5 in the juvenile type (5) . It is postulated that juvenile rheumatoid arthritis comprises several different subtypes and the majority of the subtypes are distinct from adult rheumatoid arthritis (27) .
Several hypotheses can explain the similar phenomenon in myasthenia gravis. The first hypothesis is that they comprise a single disease entity, but the presence of certain HLA antigens precipitates the disease onset, or the presence of HLA antigens are significant only at a certain stage of the immune and neuromuscular system development. It is also possible that the environmental and other acquired pathological factors dilute relative significance of HLA-related factors in the late-onset type. The supporting evidence for this argument is the general similarity of clinical signs and symptoms (marked responsiveness to the Tensilon test, diurnal fluctuation ofthe symptoms, and characteristic electromyographic findings, etc.) in both childhood and adulthood onset MG.
An alternative explanation is that MG with early childhood onset comprises a completely different subset of the disorder. This hypothesis is more tempting, since the difference in the HLA association in MG compares with that found in diabetes mellitus and rheumatoid arthritis. The other supporting evidence for this hypothesis includes the differences in the fine clinical signs and symptoms between adult-onset and childhood-onset MG (10, (12) (13) (14) (15) (16) . The corticosteroid therapy is more effective and thus complete remission is more common in childhood-onset MG. Mumps infection often leads to complete remission in childhood-onset MG (12, 13 It should be noted that the childhood-onset MG mostly follows the benign course. The early death is rare, most children enter into partial or complete remission, and after a period of successful control, adulthood recurrence is rare (12) (13) (14) (15) (16) . Thus the "early death" hypothesis that most of the childhood-onset patients die early in their life and that affects the HLA frequencies in adulthood cannot be applied to MG.
In subgroup I, two different statistical analyses showed the presence of synergistic interaction between DR9 and DRw 13 (and DQwl and DQw3). According to the method of Rothman, the relative risk for the DR9/DRwl 3 heterozygotes was 8.63 times higher than that expected under no synergistic interaction. All the single disease allele models that did not consider synergistic interaction failed to explain the observed HLA frequencies. However, the observed HLA frequencies meshed well with the model proposed by Louis and Thomson that employed synergistic interaction between the multiple disease alleles (26) All the possible combinations of the DR and DQ genes were examined for 23 patients. Each number in the cell denotes the number of the patients who had the specific combination. Parenthesis denotes the combination usually found in Japanese with strong haplotypic association (24, 31) . Among the unusual combinations DQA 1 Taq I 6.0 kb/DQB I Taq 1 1.9 kb was the most frequent.
[25]) and DQB Taq 1 1.9 kb (found in the DQw9 and other haplotypes [34] All the subjects showed the DQA1 Taq I 5.4-kb and DQB Taq I 1.9-kb fragments. The attributable risks for these fragments were 1.0. This indicates that, should these fragments be absent, there would be little, if any, chance that the subjects develops childhood-onset MG. This suggests that these fragments may be a necessity in developing childhood-onset MG, although they may not contribute the disease-susceptibility as much as other markers such as DR9/DRw 13 heterozygosity. DP (RFLP) was similar to that found in controls. This suggests that the putative disease-susceptibility locus to childhood-onset MG is located more adjacent to the DR or the DQ locus rather than the DP locus.
The family study revealed discordance in two monozygotic and one dizygotic twins. This finding suggests that nongenetic factors are also required in developing MG.
The DR9 haplotypes in the patients were diverse. The second most frequent DR9 haplotype in the patients studied was Cwl l-Bw46-BFS-C4A4B2-DR9-DQw3. This haplotype is rare in control Japanese, but found frequently in Chinese MG patients (35) . This extended haplotype may play a similar role in developing MG in these two Oriental populations. The diversity of DR9 haplotypes, however, suggests that the specific allele(s) on DR9 haplotypes, such as DR9 and DQw9, would be more important than the haplotype.
The more interesting finding is that nearly 90% of the DRw1 3 haplotypes in the patients were C blank-B44-BFF-C4A3-C4B l-DRw13-DQwl. Recent (37) . An interesting possibility is that the B44-DRw I 3-DQw 1 haplotype in Japanese and the B8-DR3-DQw2 haplotype in caucasian share or lack a certain ancestral gene, and that the gene confers the susceptibility to MG in two different populations (Fig. 5) . One of such candidates is tumor necrosis factor (TNF). Dawkins and colleagues (38) 
